GIOVANNONI, ROBERTO
GIOVANNONI, ROBERTO
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
2019 F. Giordano, V. Vaira, D. Cortinovis, S. Bonomo, J. Goedmakers, F. Brena, A. Cialdella, L. Ianzano, I. Forno, M.G. Cerrito, R. Giovannoni, G.L. Ferri, E. Tasciotti, S. Vicent, F. Damarco, S. Bosari, M. Lavitrano, E. Grassilli
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
2019 C.R. Sirtori, M. Ruscica, L. Calabresi, G. Chiesa, R. Giovannoni, J.L. Badimon
Microarray analysis of liver gene expression in Apoa-I Milano knock-in mouse models
2018 C. Parolini, R. Brambilla, G.S. Ganzetti, E. Rigamonti, R. Giovannoni
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma | 2019 | Vaira V.Cortinovis D.Bonomo S.Forno I.Giovannoni R.Damarco F.Bosari S. + | Article (author) | - | |
| HDL therapy today: from atherosclerosis, to stent compatibility to heart failure | 2019 | Sirtori, C RRuscica, MCalabresi, LChiesa, GGiovannoni, R + | Article (author) | - | |
| Microarray analysis of liver gene expression in Apoa-I Milano knock-in mouse models | 2018 | C. ParoliniG. S. GanzettiE. RigamontiR. Giovannoni + | Article (author) | - |